(Q30351951)

20 June 2017

title

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine. (English)

1 reference

20 June 2017

1 reference

1 reference

Keyang Wang

1

1 reference

20 June 2017

Kathleen M Holtz

2

1 reference

20 June 2017

Karl Anderson

3

1 reference

20 June 2017

Richard Chubet

4

1 reference

20 June 2017

Wafaa Mahmoud

5

1 reference

20 June 2017

Manon M J Cox

6

1 reference

20 June 2017

language of work or name

English

0 references

publication date

10 November 2005

1 reference

20 June 2017

number of pages

10

1 reference

inferred from page(s)

published in

Vaccine

1 reference

20 June 2017

volume

24

1 reference

20 June 2017

issue

12

1 reference

20 June 2017

page(s)

2176-2185

1 reference

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Serious morbidity and mortality associated with influenza epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

7 January 2021

12 December 2020

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Confronting the avian influenza threat: vaccine development for a potential pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Probable person-to-person transmission of avian influenza A (H5N1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

The role of cell culture vaccines in the control of the next influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Next generation flu vaccine boosted by Chiron debacle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Preparing for the next pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Antigenic drift and efficacy of influenza virus vaccines, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Evidence for host-cell selection of influenza virus antigenic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Immunochemical quantitation of antigens by single radial immunodiffusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Assembly of influenza hemagglutinin trimers and its role in intracellular transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

The state of biopharmaceutical manufacturing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Insect cell culture for industrial production of recombinant proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Recombinant protein expression for therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Hydroxyapatite chromatography: altering the phosphate-dependent elution profile of protein as a function of pH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Separation between the alpha and beta forms of human antithrombin by hydroxyapatite high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Importance of hemagglutinin glycosylation for the biological functions of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Effects of glycosylation on the properties and functions of influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Roles of N-linked glycans in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

7 January 2021

inferred from DOI database lookup

Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.005

7 January 2021

inferred from DOI database lookup

The chaperone activity of bovine alpha crystallin. Interaction with other lens crystallins in native and denatured states.

1 reference

12 December 2020

A Phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line

1 reference

12 December 2020

Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine

1 reference

12 December 2020

Cell-based protein vaccines for influenza

1 reference

12 December 2020

Production of recombinant proteins: challenges and solutions

1 reference

12 December 2020

10.1016/J.VACCINE.2005.11.005

Identifiers

DOI

1 reference

20 June 2017

0 references

1 reference